These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28625478)

  • 1. A neonatal mouse model of coxsackievirus A10 infection for anti-viral evaluation.
    Li S; Zhao H; Yang L; Hou W; Xu L; Wu Y; Wang W; Chen C; Wan J; Ye X; Liang Z; Mao Q; Cheng T; Xia N
    Antiviral Res; 2017 Aug; 144():247-255. PubMed ID: 28625478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.
    Zhang Z; Dong Z; Li J; Carr MJ; Zhuang D; Wang J; Zhang Y; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle destruction caused by coxsackievirus A10 in gerbils: Construction of a novel animal model for antiviral evaluation.
    Chen C; Xia Y; Zhu S; Xu F; Sun Y; Lu H; Gao M; Yang Z; Mao Z; Ge Q; Miao Z; Zhu H; Yao P
    Virus Res; 2020 Sep; 286():198067. PubMed ID: 32553610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
    Zhang Z; Dong Z; Wei Q; Carr MJ; Li J; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 May; 91(9):. PubMed ID: 28250116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A murine model of coxsackievirus A16 infection for anti-viral evaluation.
    Liu Q; Shi J; Huang X; Liu F; Cai Y; Lan K; Huang Z
    Antiviral Res; 2014 May; 105():26-31. PubMed ID: 24583030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A neonatal mouse model for the evaluation of antibodies and vaccines against coxsackievirus A6.
    Yang L; Mao Q; Li S; Gao F; Zhao H; Liu Y; Wan J; Ye X; Xia N; Cheng T; Liang Z
    Antiviral Res; 2016 Oct; 134():50-57. PubMed ID: 27582066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge.
    Shen C; Liu Q; Zhou Y; Ku Z; Wang L; Lan K; Ye X; Huang Z
    Vaccine; 2016 Sep; 34(41):5005-5012. PubMed ID: 27562093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant virus-like particle presenting a newly identified coxsackievirus A10 neutralization epitope induces protective immunity in mice.
    Dai W; Xiong P; Zhang X; Liu Z; Chen J; Zhou Y; Ye X; Zhang C
    Antiviral Res; 2019 Apr; 164():139-146. PubMed ID: 30817941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation characteristics of coxsackievirus A10 in mice and immune protection ability of experimental inactivated vaccine.
    Gao W; Yue L; Yang T; Shen D; Li H; Song X; Xie T; He X; Xie Z
    Biomed Pharmacother; 2021 Nov; 143():112212. PubMed ID: 34649345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neonatal mouse model of Enterovirus D68 infection induces both interstitial pneumonia and acute flaccid myelitis.
    Sun S; Bian L; Gao F; Du R; Hu Y; Fu Y; Su Y; Wu X; Mao Q; Liang Z
    Antiviral Res; 2019 Jan; 161():108-115. PubMed ID: 30503887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice.
    Zhang Z; Dong Z; Wang Q; Carr MJ; Li J; Liu T; Li D; Shi W
    Vaccine; 2018 Nov; 36(46):7095-7104. PubMed ID: 30316529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A neonatal murine model of coxsackievirus A4 infection for evaluation of vaccines and antiviral drugs.
    Zhang Z; Zhang X; Carr MJ; Zhou H; Li J; Liu S; Liu T; Xing W; Shi W
    Emerg Microbes Infect; 2019; 8(1):1445-1455. PubMed ID: 31595827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A virus-like particle vaccine protects mice against coxsackievirus A10 lethal infection.
    Zhou Y; Zhang C; Liu Q; Gong S; Geng L; Huang Z
    Antiviral Res; 2018 Apr; 152():124-130. PubMed ID: 29470994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A neonatal mouse model of coxsackievirus A16 for vaccine evaluation.
    Mao Q; Wang Y; Gao R; Shao J; Yao X; Lang S; Wang C; Mao P; Liang Z; Wang J
    J Virol; 2012 Nov; 86(22):11967-76. PubMed ID: 22951825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human SCARB2 Acts as a Cellular Associator for Helping Coxsackieviruses A10 Infection.
    Yu SL; Chung NH; Lin YC; Liao YA; Chen YC; Chow YH
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propagation and immunological characterization of coxsackievirus A10 in a serum-free HEK293A cell culture system.
    Lien SC; Shen YS; Lin HY; Wu SR; Fang CY; Chen CH; Chen YA; Chong PC; Huang MH; Chow YH; Wang JR; Wu SC; Liu CC
    Virus Res; 2023 May; 329():199101. PubMed ID: 36958398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Mouse Model of Enterovirus D68 Infection for Assessment of the Efficacy of Inactivated Vaccine.
    Zhang C; Zhang X; Dai W; Liu Q; Xiong P; Wang S; Geng L; Gong S; Huang Z
    Viruses; 2018 Jan; 10(2):. PubMed ID: 29385753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A neonatal mouse model of central nervous system infections caused by Coxsackievirus B5.
    Mao Q; Hao X; Hu Y; Du R; Lang S; Bian L; Gao F; Yang C; Cui B; Zhu F; Shen L; Liang Z
    Emerg Microbes Infect; 2018 Nov; 7(1):185. PubMed ID: 30459302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of A Neonatal Mouse Model for Coxsackievirus B1 Antiviral Evaluation.
    Yin Z; Wu Y; Zhu R; Xu L; Lin Y; Yang H; Fu W; Huang Q; Zhang D; Wang J; Wang W; Wang Y; Cheng T; Xia N
    Virol Sin; 2021 Dec; 36(6):1575-1584. PubMed ID: 34581960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An adult gerbil model for evaluating potential coxsackievirus A16 vaccine candidates.
    Yao PP; Miao ZP; Xu F; Lu HJ; Sun YS; Xia Y; Chen C; Yang ZN; Xia SC; Jiang JM; Hu CG; Mao ZA; Gao M; Xu ZY; Ying HN; Yao CH; Zhu ZY; Zhu HP; Xiang HQ
    Vaccine; 2019 Aug; 37(36):5341-5349. PubMed ID: 31351798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.